Peptides and peptidomimetics as regulators of protein–protein interactions

AD Cunningham, N Qvit, D Mochly-Rosen - Current opinion in structural …, 2017 - Elsevier
Highlights•Protein–protein interactions are essential for almost all cell processes.•Peptides
are ideal candidates for targeting protein–protein interactions (PPIs).•We survey screening …

Interfering peptides targeting protein–protein interactions: the next generation of drugs?

H Bruzzoni-Giovanelli, V Alezra, N Wolff, CZ Dong… - Drug Discovery …, 2018 - Elsevier
Highlights•Structure-based strategies allow more-specific targeting of protein–protein
interactions (PPIs).•Interfering peptides (IPs) become a promising alternative to small …

Correcting mitochondrial fusion by manipulating mitofusin conformations

A Franco, RN Kitsis, JA Fleischer, E Gavathiotis… - Nature, 2016 - nature.com
Mitochondria are dynamic organelles that exchange contents and undergo remodelling
during cyclic fusion and fission. Genetic mutations in MFN2 (the gene encoding mitofusin 2) …

Converting peptides into drugs targeting intracellular protein–protein interactions

GJB Philippe, DJ Craik, ST Henriques - Drug Discovery Today, 2021 - Elsevier
Highlights•Cyclic peptides are ideal inhibitors of protein–protein interactions (PPIs), due to
low immunogenicity and large surface area.•Peptide libraries are excellent tools to screen …

[HTML][HTML] An update on protein kinases as therapeutic targets—part I: protein kinase C activation and its role in cancer and cardiovascular diseases

S Silnitsky, SJS Rubin, M Zerihun, N Qvit - International journal of …, 2023 - mdpi.com
Protein kinases are one of the most significant drug targets in the human proteome,
historically harnessed for the treatment of cancer, cardiovascular disease, and a growing …

[HTML][HTML] The promise of graphene-based transistors for democratizing multiomics studies

HW Lu, AA Kane, J Parkinson, Y Gao, R Hajian… - Biosensors and …, 2022 - Elsevier
As biological research has synthesized genomics, proteomics, metabolomics, and
transcriptomics into systems biology, a new multiomics approach to biological research has …

A selective inhibitor of mitofusin 1-βIIPKC association improves heart failure outcome in rats

JCB Ferreira, JC Campos, N Qvit, X Qi… - Nature …, 2019 - nature.com
We previously demonstrated that beta II protein kinase C (βIIPKC) activity is elevated in
failing hearts and contributes to this pathology. Here we report that βIIPKC accumulates on …

Recent advances in pyruvate dehydrogenase kinase inhibitors: Structures, inhibitory mechanisms and biological activities

Y Li, Z **e, X Lei, X Yang, S Huang, W Yuan, X Deng… - Bioorganic …, 2024 - Elsevier
Metabolism is reprogrammed in a variety of cancer cells to ensure their rapid proliferation.
Cancer cells prefer to utilize glycolysis to produce energy as well as to provide large …

[HTML][HTML] An Update on Protein Kinases as Therapeutic Targets—Part II: Peptides as Allosteric Protein Kinase C Modulators Targeting Protein–Protein Interactions

M Zerihun, SJS Rubin, S Silnitsky, N Qvit - International Journal of …, 2023 - mdpi.com
Human protein kinases are highly-sought-after drug targets, historically harnessed for
treating cancer, cardiovascular disease, and an increasing number of autoimmune and …

Switching off IMMP2L signaling drives senescence via simultaneous metabolic alteration and blockage of cell death

L Yuan, L Zhai, L Qian, D Huang, Y Ding, H **ang… - Cell Research, 2018 - nature.com
Cellular senescence is a fundamental cell fate playing a significant role throughout the
natural aging process. However, the molecular determinants distinguishing senescence …